- Home
- TVGN vs OPFI Comparison
TVGN vs OPFI Comparison
Compare TVGN & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- OPFI
- Stock Information
- Founded
- TVGN 2020
- OPFI 2009
- Country
- TVGN United States
- OPFI United States
- Employees
- TVGN N/A
- OPFI N/A
- Industry
- TVGN Blank Checks
- OPFI Finance: Consumer Services
- Sector
- TVGN Finance
- OPFI Finance
- Exchange
- TVGN Nasdaq
- OPFI Nasdaq
- Market Cap
- TVGN 198.6M
- OPFI 205.2M
- IPO Year
- TVGN N/A
- OPFI N/A
- Fundamental
- Price
- TVGN $0.98
- OPFI $8.30
- Analyst Decision
- TVGN Strong Buy
- OPFI Buy
- Analyst Count
- TVGN 1
- OPFI 2
- Target Price
- TVGN $10.00
- OPFI $7.50
- AVG Volume (30 Days)
- TVGN 528.6K
- OPFI 1.1M
- Earning Date
- TVGN 05-28-2025
- OPFI 05-07-2025
- Dividend Yield
- TVGN N/A
- OPFI 3.03%
- EPS Growth
- TVGN N/A
- OPFI N/A
- EPS
- TVGN N/A
- OPFI 0.36
- Revenue
- TVGN N/A
- OPFI $276,770,000.00
- Revenue This Year
- TVGN N/A
- OPFI $112.50
- Revenue Next Year
- TVGN N/A
- OPFI $7.84
- P/E Ratio
- TVGN N/A
- OPFI $23.06
- Revenue Growth
- TVGN N/A
- OPFI 22.23
- 52 Week Low
- TVGN $0.26
- OPFI $2.56
- 52 Week High
- TVGN $3.09
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- TVGN 40.84
- OPFI 40.65
- Support Level
- TVGN $0.93
- OPFI $8.00
- Resistance Level
- TVGN $1.13
- OPFI $8.74
- Average True Range (ATR)
- TVGN 0.11
- OPFI 0.61
- MACD
- TVGN 0.00
- OPFI 0.01
- Stochastic Oscillator
- TVGN 25.00
- OPFI 32.76
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.